Mariner
UTHR icon

Mariner’s United Therapeutics UTHR Stock Holding History

Mariner’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
23,965
-3,972
-14% -$2.24M 0.01% 620
2026
Q1 		$16.6M Buy
27,937
+2,754
+11% +$1.37M 0.02% 536
2025
Q4 		$12.3M Buy
25,183
+18,213
+261% +$8.48M 0.01% 614
2025
Q3 		$2.92M Buy
6,970
+2,001
+40% +$673K ﹤0.01% 1204
2025
Q2 		$1.43M Buy
4,969
+698
+16% +$209K ﹤0.01% 1550
2025
Q1 		$1.32M Buy
4,271
+71
+2% +$24.3K ﹤0.01% 1499
2024
Q4 		$1.48M Buy
4,200
+299
+8% +$110K ﹤0.01% 1383
2024
Q3 		$1.4M Sell
3,901
-147
-4% -$49.7K ﹤0.01% 1392
2024
Q2 		$1.29M Buy
4,048
+800
+25% +$212K ﹤0.01% 1347
2024
Q1 		$747K Sell
3,248
-591
-15% -$133K ﹤0.01% 1727
2023
Q4 		$844K Buy
3,839
+474
+14% +$109K ﹤0.01% 1552
2023
Q3 		$760K Buy
3,365
+275
+9% +$63.3K ﹤0.01% 1493
2023
Q2 		$682K Buy
3,090
+184
+6% +$40.8K ﹤0.01% 1539
2023
Q1 		$649K Sell
2,906
-230
-7% -$56.7K ﹤0.01% 1538
2022
Q4 		$872K Buy
3,136
+707
+29% +$178K ﹤0.01% 1314
2022
Q3 		$508K Buy
+2,429
New +$543K ﹤0.01% 1408

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Mariner's UTHR Position: Q2 2026 in Review

Mariner reduced its United Therapeutics (UTHR) stake by 14% in Q2 2026, selling an estimated $2.24M and leaving 23,965 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #620.

Mariner first reported a position in UTHR in Q3 2022 and has held it in 16 quarters since. The position peaked at $16.6M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Mariner held 23,965 shares of United Therapeutics worth $13M as of Q2 2026.
  • Mariner sold 3,972 United Therapeutics shares in Q2 2026, an estimated $2.24M.
  • United Therapeutics made up 0.01% of Mariner's portfolio in Q2 2026, its #620 holding.
  • Mariner first reported a position in United Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Mariner's United Therapeutics position peaked at $16.6M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.